cas: 2492423-29-5 — see every product listed under this CAS number, including other names
Molnupiravir (CAS 2492423-29-5) is a chemical reagent available from Chemat. Available pack sizes: on request, 1x50mg, 5mg, 10mg, 100mg, 200mg, 25mg, 10mM (in 1ml dmso). Offered by: Chemat Brand, HPC Standards, GLPBio.
| brand | Chemat Brand |
|---|---|
| catalog number | ULM247001 |
| cas | 2492423-29-5 |
| size | on request |
| availability | Do potwierdzenia przez Chemat|To be confirmed by Chemat |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| Chemat Brand | on request | price on request | |
| HPC Standards | 1x50mg | price on request | |
| GLPBio | 5mg | 559.60 Pln | |
| GLPBio | 10mg | 643.84 Pln | |
| GLPBio | 100mg | 1055.73 Pln | |
| GLPBio | 200mg | 1481.65 Pln | |
| GLPBio | 25mg | 709.37 Pln | |
| GLPBio | 10mM (in 1ml dmso) | 667.25 Pln | |
| GLPBio | 50mg | 826.38 Pln |
| purity | No data |
|---|---|
| category | Chemicals |
| delivery time | To be confirmed by Chemat |
Molnupiravir is a nucleoside analogue that is N4-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N4-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19. It has a role as an anticoronaviral agent, an antiviral drug and a prodrug. It is a ketoxime, an isopropyl ester and a nucleoside analogue. It is functionally related to a N(4)-hydroxycytidine.
Source: ChEBI
| Molecular formula | C13H19N3O7 |
|---|---|
| Molecular weight | 329.31 g/mol |
| IUPAC name | [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate |
| InChIKey | HTNPEHXGEKVIHG-QCNRFFRDSA-N |
| SMILES | CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O |
Computed by PubChem (NCBI)